Drug profile · INN
hyaluronidase recombinant human
HYLENEX RECOMBINANT
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
hyaluronidase recombinant human (HYLENEX RECOMBINANT) is an FDA-listed pharmaceutical active ingredient. Associated with HALOZYME THERAPEUTICS, INC.. Route of administration: injection. Current US regulatory status: approved.
Key facts
Frequently asked questions
What is hyaluronidase recombinant human?
hyaluronidase recombinant human (HYLENEX RECOMBINANT) is an FDA-listed pharmaceutical active ingredient. Associated with HALOZYME THERAPEUTICS, INC.. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for hyaluronidase recombinant human?
HYLENEX RECOMBINANT is a marketed brand name for hyaluronidase recombinant human. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of hyaluronidase recombinant human?
hyaluronidase recombinant human has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.